Skip to main content
. 2012 Jul 16;7(7):e39519. doi: 10.1371/journal.pone.0039519

Table 2. Biochemical data for healthy controls and patients with mild primary hyperparathyroidism before and after parathyroidectomy.

Variable Controls PHPT PHPT Baseline
Baseline Follow-up vs. Controls vs. Follow-up
n = 48 (35 F) n = 48 (35 F) n = 48 (35 F) p-value p-value
P-PTH (10–65 ng/L) 44.0±12.5 120.0±40.4 49.6±15.7 <0.001 <0.001
P-Calcium (2.15–2.50 mmol/L) 2.29±0.08 2.61±0.12 2.27±0.08 <0.001 <0.001
S-Ca++ (1.15–1.33 mmol/L) 1.25±0.04 1.46±0.06 1.25±0.05 <0.001 <0.001
P-Phosphate (0.80–1.5 mmol/L) 1.06±0.17 0.85±0.16 1.01±0.17a <0.001 <0.001
Ca*Phosphate 2.43±0.41 2.20±0.39 2.32±0.40 <0.01 0.050
S-25-OH-D (75–250 nmol/L) 64.1±20.6b 40.6±17.1a 58.2±19.5 <0.001 <0.001
P-Creatinine (<90 µmol/L) 69.1±13.6 66.3±12.1a 68.1±15.9b 0.434 0.386
GFR, mL/min (>90 mL/min) 93.0±22.0 100.9±22.2a 103.1±27.7b 0.049 0.861
P-Glucose (4.0–6.0 mmol/L) 5.0±0.34a 5.0±0.46b 4.9±0.52a 0.523 0.471
P-hs-CRP (<3 mg/L) 1.14±1.22b 0.92±0.90a 1.95±5.05c 0.553 0.004
S-Cholesterol (3.9–7.8 mmol/L) 5.71±1.03b 5.74±0.80a 5.85±0.89 0.857 0.163
S-TG (0.45–2.6 mmol/L) 0.86±0.43b 1.00±0.54a 0.93±0.51 0.073 0.045
S-Apo-A1 (1.10–2.10 g/L) 1.73±0.32b 1.72±0.32a 1.69±0.28 0.786 0.760
S-Apo-B (0.50–1.70 g/L) 1.02±0.21 1.01±0.18a 1.06±0.17 0.954 0.003
Apo B/Apo-A1 (<1) 0.60±0.14b 0.61±0.17a 0.64±0.13 0.997 0.117
P-VWF (0.60–1.60 kIE/L) 1.11±0.40b 1.05±0.36b 1.07±0.40b 0.467 0.647
P-PAI-1 (<15 kIE/L) 10.07±6.90b 9.51±7.73b 8.69±7.49b 0.320 0.661
P-Homocysteine (5.0–15.0 µg/L) 9.30±3.00b 9.87±2.75a 9.59±2.29a 0.295 0.266
S-IGF-1 (110–270 µg/L) 137.5±52.9b 146.2±48.3a 143.6±68.2 0.323 0.086
a

n = 47,

b

n = 44–46.

c

One patient had CRP 35.40 mg/L at follow-up, after excluding the patient, mean hs-CRP was 1.26±1.09 mg/L, p<0.01. Values are shown as means±SD. F = female, P = plasma, S = serum, PTH = parathyroid hormone, S-Ca++ = ionised calcium, S-25-OH-D = 25 hydroxyvitamin D, GFR = glomerular filtration rate. P-hsCRP = high sensitivity C-reactive protein, TG = triglycerides, Apo = apolipoprotein, VWF = von Willebrand factor antigen, PAI-1 = plasminogen activator inhibitor-1 activity, IGF-1 = insulin like growth factor.